CoChat
Sign Up
Cited by 118

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

The role of microRNAs in the regulation of cancer stem cells

Takahashi, Ryou-u, Miyazaki, Hiroaki, Ochiya, Takahiro·2014·Frontiers in Genetics
DOI 10.3389/fgene.2013.00295PMC PMC3879439
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fgene.2013.00295

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 9 references

Research works printed but not linked: 122

  1. Al-Hajj M. Wicha M. S. Benito-Hernandez A. Morrison S. J. Clarke M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 3983– 3988 10.1073/pnas.0530291100 12629218 PMC153034 · DOI
  2. Arnold C. P. Tan R. Zhou B. Yue S. B. Schaffert S. Biggs J. R. (2011). MicroRNA programs in normal and aberrant stem and progenitor cells. Genome Res. 21, 798– 810 10.1101/gr.111385.110 21451113 PMC3083097 · DOI · Paper page
  3. Aziz M. H. Kumar R. Ahmad N. (2003). Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol. 23, 17– 28 12792772
  4. Bernstein E. Kim S. Y. Carmell M. A. Murchison E. P. Alcorn H. Li M. Z. (2003). Dicer is essential for mouse development. Nat. Genet. 35, 215– 217 10.1038/ng1253 14528307 · DOI · Paper page
  5. Bitarte N. Bandres E. Boni V. Zarate R. Rodriguez J. Gonzalez-Huarriz M. (2011). MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells 29, 1661– 1671 10.1002/stem.741 21948564 · DOI
  6. Boiko A. D. Razorenova O. V. Van De Rijn M. Swetter S. M. Johnson D. L. Ly D. P. (2010). Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466, 133– 137 10.1038/nature09161 20596026 PMC2898751 · DOI
  7. Bonnet D. Dick J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730– 737 10.1038/nm0797-730 9212098 · DOI
  8. Bu P. Chen K. Y. Chen J. H. Wang L. Walters J. Shin Y. J. (2013). A microRNA miR-34a-regulated bimodal switch targets notch in colon cancer stem cells. Cell Stem Cell 12, 602– 615 10.1016/j.stem.2013.03.002 23642368 PMC3646336 · DOI
  9. Burk U. Schubert J. Wellner U. Schmalhofer O. Vincan E. Spaderna S. (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582– 589 10.1038/embor.2008.74 18483486 PMC2396950 · DOI
  10. Choi Y. J. Lin C. P. Ho J. J. He X. Okada N. Bu P. (2011). miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat. Cell Biol. 13, 1353– 1360 10.1038/ncb2366 22020437 PMC3541684 · DOI
  11. Cimmino A. Calin G. A. Fabbri M. Iorio M. V. Ferracin M. Shimizu M. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U.S.A. 102, 13944– 13949 10.1073/pnas.0506654102 16166262 PMC1236577 · DOI
  12. Clevers H. (2011). The cancer stem cell: premises, promises and challenges. Nat. Med. 17, 313– 319 10.1038/nm.2304 21386835 · DOI
  13. Cohnheim J. (1875). Congenitales, quergestreiftes Muskelsarkon der Nireren. Virchows Arch. 65: 64 10.1007/BF01978936 · DOI
  14. Collins A. T. Berry P. A. Hyde C. Stower M. J. Maitland N. J. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946– 10951 10.1158/0008-5472.CAN-05-2018 16322242 · DOI
  15. Colmont C. S. Harding K. G. Piguet V. Patel G. K. (2012). Human skin cancer stem cells: a tale of mice and men. Exp. Dermatol. 21, 576– 580 10.1111/j.1600-0625.2012.01533.x 22775992 · DOI
  16. Costinean S. Zanesi N. Pekarsky Y. Tili E. Volinia S. Heerema N. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 103, 7024– 7029 10.1073/pnas.0602266103 16641092 PMC1459012 · DOI
  17. Dalerba P. Dylla S. J. Park I. K. Liu R. Wang X. Cho R. W. (2007). Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. U.S.A. 104, 10158– 10163 10.1073/pnas.0703478104 17548814 PMC1891215 · DOI
  18. Eramo A. Lotti F. Sette G. Pilozzi E. Biffoni M. Di Virgilio A. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15, 504– 514 10.1038/sj.cdd.4402283 18049477 · DOI
  19. Fang D. Nguyen T. K. Leishear K. Finko R. Kulp A. N. Hotz S. (2005). A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65, 9328– 9337 10.1158/0008-5472.CAN-05-1343 16230395 · DOI · Paper page
  20. Fuchs D. Daniel V. Sadeghi M. Opelz G. Naujokat C. (2010). Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem. Biophys. Res. Commun. 394, 1098– 1104 10.1016/j.bbrc.2010.03.138 20350531 · DOI
  21. Garzia L. Andolfo I. Cusanelli E. Marino N. Petrosino G. De Martino D. (2009). MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS ONE 4: e4998 10.1371/journal.pone.0004998 19308264 PMC2656623 · DOI
  22. Ginestier C. Hur M. H. Charafe-Jauffret E. Monville F. Dutcher J. Brown M. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555– 567 10.1016/j.stem.2007.08.014 18371393 PMC2423808 · DOI
  23. Giordano A. Gao H. Cohen E. N. Anfossi S. Khoury J. Hess K. (2013). Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients. Ann. Oncol. 24, 2515– 2521 10.1093/annonc/mdt223 23798614 PMC3784333 · DOI
  24. Godlewski J. Newton H. B. Chiocca E. A. Lawler S. E. (2010). MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ. 17, 221– 228 10.1038/cdd.2009.71 19521422 · DOI · Paper page
  25. Godlewski J. Nowicki M. O. Bronisz A. Williams S. Otsuki A. Nuovo G. (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68, 9125– 9130 10.1158/0008-5472.CAN-08-2629 19010882 · DOI · Paper page
  26. Gregory R. I. Yan K. P. Amuthan G. Chendrimada T. Doratotaj B. Cooch N. (2004). The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235– 240 10.1038/nature03120 15531877 · DOI
  27. Gregory P. A. Bert A. G. Paterson E. L. Barry S. C. Tsykin A. Farshid G. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593– 601 10.1038/ncb1722 18376396 · DOI
  28. Gupta P. B. Onder T. T. Jiang G. Tao K. Kuperwasser C. Weinberg R. A. (2009). Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138, 645– 659 10.1016/j.cell.2009.06.034 19682730 PMC4892125 · DOI
  29. Hagiwara K. Kosaka N. Yoshioka Y. Takahashi R. U. Takeshita F. Ochiya T. (2012). Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity. Sci. Rep. 2, 314 10.1038/srep00314 22423322 PMC3304512 · DOI
  30. Han Y. C. Park C. Y. Bhagat G. Zhang J. Wang Y. Fan J. B. (2010). microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J. Exp. Med. 207, 475– 489 10.1084/jem.20090831 20212066 PMC2839143 · DOI
  31. He L. Thomson J. M. Hemann M. T. Hernando-Monge E. Mu D. Goodson S. (2005). A microRNA polycistron as a potential human oncogene. Nature 435, 828– 833 10.1038/nature03552 15944707 PMC4599349 · DOI
  32. Hermann P. C. Huber S. L. Herrler T. Aicher A. Ellwart J. W. Guba M. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313– 323 10.1016/j.stem.2007.06.002 18371365 · DOI
  33. Hoey T. Yen W. C. Axelrod F. Basi J. Donigian L. Dylla S. (2009). DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 5, 168– 177 10.1016/j.stem.2009.05.019 19664991 · DOI
  34. Hsieh I. S. Chang K. C. Tsai Y. T. Ke J. Y. Lu P. J. Lee K. H. (2013). MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis 34, 530– 538 10.1093/carcin/bgs371 23188675 · DOI
  35. Ibarra I. Erlich Y. Muthuswamy S. K. Sachidanandam R. Hannon G. J. (2007). A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev. 21, 3238– 3243 10.1101/gad.1616307 18079172 PMC2113025 · DOI
  36. Iliopoulos D. Rotem A. Struhl K. (2011). Inhibition of miR-193a expression by Max and RXRalpha activates K-Ras and PLAU to mediate distinct aspects of cellular transformation. Cancer Res. 71, 5144– 5153 10.1158/0008-5472.CAN-11-0425 21670079 PMC3148313 · DOI
  37. Iorio M. V. Croce C. M. (2012). MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 4, 143– 159 10.1002/emmm.201100209 22351564 PMC3376845 · DOI
  38. Johnson S. M. Grosshans H. Shingara J. Byrom M. Jarvis R. Cheng A. (2005). RAS is regulated by the let-7 microRNA family. Cell 120, 635– 647 10.1016/j.cell.2005.01.014 15766527 · DOI
  39. Kakarala M. Brenner D. E. Korkaya H. Cheng C. Tazi K. Ginestier C. (2010). Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res. Treat. 122, 777– 785 10.1007/s10549-009-0612-x 19898931 PMC3039120 · DOI
  40. Karamboulas C. Ailles L. (2013). Developmental signaling pathways in cancer stem cells of solid tumors. Biochim. Biophys. Acta 1830, 2481– 2495 10.1016/j.bbagen.2012.11.008 23196196 · DOI
  41. Karsten U. Goletz S. (2013). What makes cancer stem cell markers different? Springerplus 2, 301 10.1186/2193-1801-2-301 23888272 PMC3710573 · DOI
  42. Kashat M. Azzouz L. Sarkar S. H. Kong D. Li Y. Sarkar F. H. (2012). Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness. Am. J. Transl. Res. 4, 432– 442 23145211 PMC3493023
  43. Kim H. Lee G. Ganat Y. Papapetrou E. P. Lipchina I. Socci N. D. (2011). miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell 8, 695– 706 10.1016/j.stem.2011.04.002 21624813 · DOI
  44. Kobayashi S. Yamada-Okabe H. Suzuki M. Natori O. Kato A. Matsubara K. (2012). LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution. Stem Cells 30, 2631– 2644 10.1002/stem.1257 23081779 · DOI
  45. Lee A. Kessler J. D. Read T. A. Kaiser C. Corbeil D. Huttner W. B. (2005). Isolation of neural stem cells from the postnatal cerebellum. Nat. Neurosci. 8, 723– 729 10.1038/nn1473 15908947 PMC2377345 · DOI
  46. Lee R. C. Feinbaum R. L. Ambros V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843– 854 10.1016/0092-8674(93)90529-Y 8252621 · DOI · Paper page
  47. Lee Y. Kim M. Han J. Yeom K. H. Lee S. Baek S. H. (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051– 4060 10.1038/sj.emboj.7600385 15372072 PMC524334 · DOI
  48. Li C. Heidt D. G. Dalerba P. Burant C. F. Zhang L. Adsay V. (2007a). Identification of pancreatic cancer stem cells. Cancer Res. 67, 1030– 1037 10.1158/0008-5472.CAN-06-2030 17283135 · DOI
  49. Li O. Li J. Droge P. (2007b). DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells. FEBS Lett. 581, 3533– 3537 10.1016/j.febslet.2007.06.072 17624332 · DOI
  50. Li Y. Guessous F. Zhang Y. Dipierro C. Kefas B. Johnson E. (2009). MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 69, 7569– 7576 10.1158/0008-5472.CAN-09-0529 19773441 PMC2756313 · DOI · Paper page
  51. Li Y. Wicha M. S. Schwartz S. J. Sun D. (2011). Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds. J. Nutr. Biochem. 22, 799– 806 10.1016/j.jnutbio.2010.11.001 21295962 PMC3248810 · DOI
  52. Li Y. Zhang T. Korkaya H. Liu S. Lee H. F. Newman B. (2010). Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin. Cancer Res. 16, 2580– 2590 10.1158/1078-0432.CCR-09-2937 20388854 PMC2862133 · DOI
  53. Lin S. L. Chang D. C. Chang-Lin S. Lin C. H. Wu D. T. Chen D. T. (2008). Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 14, 2115– 2124 10.1261/rna.1162708 18755840 PMC2553732 · DOI
  54. Liu C. Kelnar K. Liu B. Chen X. Calhoun-Davis T. Li H. (2011). The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 17, 211– 215 10.1038/nm.2284 21240262 PMC3076220 · DOI
  55. Liu N. Chen N. Y. Cui R. X. Li W. F. Li Y. Wei R. R. (2012). Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol. 13, 633– 641 10.1016/S1470-2045(12)70102-X 22560814 · DOI
  56. Liu S. Dontu G. Mantle I. D. Patel S. Ahn N. S. Jackson K. W. (2006). Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 66, 6063– 6071 10.1158/0008-5472.CAN-06-0054 16778178 PMC4386278 · DOI
  57. Lu D. Choi M. Y. Yu J. Castro J. E. Kipps T. J. Carson D. A. (2011). Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc. Natl. Acad. Sci. U.S.A. 108, 13253– 13257 10.1073/pnas.1110431108 21788521 PMC3156152 · DOI
  58. Mak A. B. Nixon A. M. Kittanakom S. Stewart J. M. Chen G. I. Curak J. (2012). Regulation of CD133 by HDAC6 promotes beta-catenin signaling to suppress cancer cell differentiation. Cell Rep. 2, 951– 963 10.1016/j.celrep.2012.09.016 23084749 PMC3590846 · DOI
  59. Mandke P. Wyatt N. Fraser J. Bates B. Berberich S. J. Markey M. P. (2012). MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLoS ONE 7: e42034 10.1371/journal.pone.0042034 22870278 PMC3411609 · DOI
  60. Mani S. A. Guo W. Liao M. J. Eaton E. N. Ayyanan A. Zhou A. Y. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704– 715 10.1016/j.cell.2008.03.027 18485877 PMC2728032 · DOI
  61. Melton C. Judson R. L. Blelloch R. (2010). Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463, 621– 626 10.1038/nature08725 20054295 PMC2894702 · DOI
  62. Merlos-Suarez A. Barriga F. M. Jung P. Iglesias M. Cespedes M. V. Rossell D. (2011). The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8, 511– 524 10.1016/j.stem.2011.02.020 21419747 · DOI · Paper page
  63. Miraglia S. Godfrey W. Yin A. H. Atkins K. Warnke R. Holden J. T. (1997). A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90, 5013– 5021 9389721
  64. Mittelbrunn M. Gutierrez-Vazquez C. Villarroya-Beltri C. Gonzalez S. Sanchez-Cabo F. Gonzalez M. A. (2011). Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282 10.1038/ncomms1285 21505438 PMC3104548 · DOI
  65. Molofsky A. V. Pardal R. Iwashita T. Park I. K. Clarke M. F. Morrison S. J. (2003). Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425, 962– 967 10.1038/nature02060 14574365 PMC2614897 · DOI
  66. Munoz J. L. Bliss S. A. Greco S. J. Ramkissoon S. H. Ligon K. L. Rameshwar P. (2013). Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol. Ther. Nucleic Acids 2, e126 10.1038/mtna.2013.60 24084846 PMC4027430 · DOI
  67. Naujokat C. Steinhart R. (2012). Salinomycin as a drug for targeting human cancer stem cells. J. Biomed. Biotechnol. 2012, 950658 10.1155/2012/950658 23251084 PMC3516046 · DOI
  68. Nishi K. Nishi A. Nagasawa T. Ui-Tei K. (2013). Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus. RNA 19, 17– 35 10.1261/rna.034769.112 23150874 PMC3527724 · DOI · Paper page
  69. O'brien C. A. Kreso A. Ryan P. Hermans K. G. Gibson L. Wang Y. (2012). ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell 21, 777– 792 10.1016/j.ccr.2012.04.036 22698403 · DOI
  70. O'brien C. A. Pollett A. Gallinger S. Dick J. E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106– 110 10.1038/nature05372 17122772 · DOI
  71. O'connell R. M. Rao D. S. Chaudhuri A. A. Boldin M. P. Taganov K. D. Nicoll J. (2008). Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 205, 585– 594 10.1084/jem.20072108 18299402 PMC2275382 · DOI · Paper page
  72. Orom U. A. Nielsen F. C. Lund A. H. (2008). MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 30, 460– 471 10.1016/j.molcel.2008.05.001 18498749 · DOI · Paper page
  73. Pang R. Law W. L. Chu A. C. Poon J. T. Lam C. S. Chow A. K. (2010). A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 6, 603– 615 10.1016/j.stem.2010.04.001 20569697 · DOI
  74. Park S. M. Gaur A. B. Lengyel E. Peter M. E. (2008). The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894– 907 10.1101/gad.1640608 18381893 PMC2279201 · DOI · Paper page
  75. Pasquinelli A. E. Reinhart B. J. Slack F. Martindale M. Q. Kuroda M. I. Maller B. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86– 89 10.1038/35040556 11081512 · DOI
  76. Patel K. R. Andreadi C. Britton R. G. Horner-Glister E. Karmokar A. Sale S. (2013). Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci. Transl. Med. 5, 205ra133 10.1126/scitranslmed.3005870 24089405 · DOI
  77. Patrawala L. Calhoun-Davis T. Schneider-Broussard R. Tang D. G. (2007). Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res. 67, 6796– 6805 10.1158/0008-5472.CAN-07-0490 17638891 · DOI
  78. Patrawala L. Calhoun T. Schneider-Broussard R. Li H. Bhatia B. Tang S. (2006). Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25, 1696– 1708 10.1038/sj.onc.1209327 16449977 · DOI
  79. Pietersen A. M. Evers B. Prasad A. A. Tanger E. Cornelissen-Steijger P. Jonkers J. (2008). Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr. Biol. 18, 1094– 1099 10.1016/j.cub.2008.06.070 18635350 · DOI
  80. Prasad K. (2012). Resveratrol, wine, and atherosclerosis. Int. J. Angiol. 21, 7– 18 10.1055/s-0032-1306417 23450206 PMC3444029 · DOI
  81. Qin J. Liu X. Laffin B. Chen X. Choy G. Jeter C. R. (2012). The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10, 556– 569 10.1016/j.stem.2012.03.009 22560078 PMC3348510 · DOI
  82. Ramakrishnaiah V. Thumann C. Fofana I. Habersetzer F. Pan Q. De Ruiter P. E. (2013). Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc. Natl. Acad. Sci. U.S.A. 110, 13109– 13113 10.1073/pnas.1221899110 23878230 PMC3740869 · DOI
  83. Reinhart B. J. Slack F. J. Basson M. Pasquinelli A. E. Bettinger J. C. Rougvie A. E. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901– 906 10.1038/35002607 10706289 · DOI
  84. Reya T. Morrison S. J. Clarke M. F. Weissman I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105– 111 10.1038/35102167 11689955 · DOI · Paper page
  85. Ricci-Vitiani L. Lombardi D. G. Pilozzi E. Biffoni M. Todaro M. Peschle C. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111– 115 10.1038/nature05384 17122771 · DOI
  86. Sachlos E. Risueno R. M. Laronde S. Shapovalova Z. Lee J. H. Russell J. (2012). Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell 149, 1284– 1297 10.1016/j.cell.2012.03.049 22632761 · DOI
  87. Schraivogel D. Weinmann L. Beier D. Tabatabai G. Eichner A. Zhu J. Y. (2011). CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBO J. 30, 4309– 4322 10.1038/emboj.2011.301 21857646 PMC3199389 · DOI
  88. Shiohama A. Sasaki T. Noda S. Minoshima S. Shimizu N. (2003). Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region. Biochem. Biophys. Res. Commun. 304, 184– 190 10.1016/S0006-291X(03)00554-0 12705904 · DOI
  89. Shimono Y. Zabala M. Cho R. W. Lobo N. Dalerba P. Qian D. (2009). Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592– 603 10.1016/j.cell.2009.07.011 19665978 PMC2731699 · DOI
  90. Singh S. K. Clarke I. D. Terasaki M. Bonn V. E. Hawkins C. Squire J. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821– 5828 14522905
  91. Singh S. K. Hawkins C. Clarke I. D. Squire J. A. Bayani J. Hide T. (2004). Identification of human brain tumour initiating cells. Nature 432, 396– 401 10.1038/nature03128 15549107 · DOI
  92. Sinkkonen L. Hugenschmidt T. Berninger P. Gaidatzis D. Mohn F. Artus-Revel C. G. (2008). MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 15, 259– 267 10.1038/nsmb.1391 18311153 · DOI
  93. Song S. J. Ito K. Ala U. Kats L. Webster K. Sun S. M. (2013a). The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 13, 87– 101 10.1016/j.stem.2013.06.003 23827711 PMC3767186 · DOI
  94. Song S. J. Poliseno L. Song M. S. Ala U. Webster K. Ng C. (2013b). MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 154, 311– 324 10.1016/j.cell.2013.06.026 23830207 PMC3767157 · DOI
  95. Stadler B. Ivanovska I. Mehta K. Song S. Nelson A. Tan Y. (2010). Characterization of microRNAs involved in embryonic stem cell states. Stem Cells Dev. 19, 935– 950 10.1089/scd.2009.0426 20128659 PMC3128320 · DOI
  96. Takaishi S. Okumura T. Tu S. Wang S. S. Shibata W. Vigneshwaran R. (2009). Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27, 1006– 1020 10.1002/stem.30 19415765 PMC2746367 · DOI
  97. Takamizawa J. Konishi H. Yanagisawa K. Tomida S. Osada H. Endoh H. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753– 3756 10.1158/0008-5472.CAN-04-0637 15172979 · DOI
  98. Taketo M. M. (2011). Reflections on the spread of metastasis to cancer prevention. Cancer Prev. Res. (Phila.) 4, 324– 328 10.1158/1940-6207.CAPR-11-0046 21372032 · DOI
  99. Takezaki T. Hide T. Takanaga H. Nakamura H. Kuratsu J. Kondo T. (2011). Essential role of the Hedgehog signaling pathway in human glioma-initiating cells. Cancer Sci. 102, 1306– 1312 10.1111/j.1349-7006.2011.01943.x 21453386 PMC11158128 · DOI
  100. Tang Q. L. Zhao Z. Q. Li J. C. Liang Y. Yin J. Q. Zou C. Y. (2011). Salinomycin inhibits osteosarcoma by targeting its tumor stem cells. Cancer Lett. 311, 113– 121 10.1016/j.canlet.2011.07.016 21835542 · DOI
  101. Tavazoie S. F. Alarcon C. Oskarsson T. Padua D. Wang Q. Bos P. D. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147– 152 10.1038/nature06487 18185580 PMC2782491 · DOI
  102. Tazawa H. Tsuchiya N. Izumiya M. Nakagama H. (2007). Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. U.S.A. 104, 15472– 15477 10.1073/pnas.0707351104 17875987 PMC2000550 · DOI
  103. To K. K. Zhan Z. Litman T. Bates S. E. (2008). Regulation of ABCG2 expression at the 3′ untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol. Cell. Biol. 28, 5147– 5161 10.1128/MCB.00331-08 18573883 PMC2519722 · DOI
  104. Uchida N. Buck D. W. He D. Reitsma M. J. Masek M. Phan T. V. (2000). Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. U.S.A. 97, 14720– 14725 10.1073/pnas.97.26.14720 11121071 PMC18985 · DOI
  105. Uchino K. Takeshita F. Takahashi R. U. Kosaka N. Fujiwara K. Naruoka H. (2013). Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression. Mol. Ther. 21, 610– 619 10.1038/mt.2012.269 23295946 PMC3589153 · DOI
  106. Varnat F. Duquet A. Malerba M. Zbinden M. Mas C. Gervaz P. (2009). Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol. Med. 1, 338– 351 10.1002/emmm.200900039 20049737 PMC3378144 · DOI
  107. Vasudevan S. Tong Y. Steitz J. A. (2007). Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931– 1934 10.1126/science.1149460 18048652 · DOI
  108. Vermeulen L. De Sousa E. M. F. Van Der Heijden M. Cameron K. De Jong J. H. Borovski T. (2010). Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 12, 468– 476 10.1038/ncb2048 20418870 · DOI · Paper page
  109. Vermeulen L. Todaro M. De Sousa Mello F. Sprick M. R. Kemper K. Perez Alea M. (2008). Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. U.S.A. 105, 13427– 13432 10.1073/pnas.0805706105 18765800 PMC2533206 · DOI
  110. Viswanathan S. R. Daley G. Q. Gregory R. I. (2008). Selective blockade of microRNA processing by Lin28. Science 320, 97– 100 10.1126/science.1154040 18292307 PMC3368499 · DOI
  111. Volinia S. Croce C. M. (2013). Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc. Natl. Acad. Sci. U.S.A. 110, 7413– 7417 10.1073/pnas.1304977110 23589849 PMC3645522 · DOI · Paper page
  112. Wang Y. Baskerville S. Shenoy A. Babiarz J. E. Baehner L. Blelloch R. (2008). Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat. Genet. 40, 1478– 1483 10.1038/ng.250 18978791 PMC2630798 · DOI
  113. Wang Y. Medvid R. Melton C. Jaenisch R. Blelloch R. (2007). DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet. 39, 380– 385 10.1038/ng1969 17259983 PMC3008549 · DOI
  114. Wei Y. Jiang Y. Zou F. Liu Y. Wang S. Xu N. (2013). Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proc. Natl. Acad. Sci. U.S.A. 110, 6829– 6834 10.1073/pnas.1217002110 23569237 PMC3637720 · DOI
  115. Weichert W. Knosel T. Bellach J. Dietel M. Kristiansen G. (2004). ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J. Clin. Pathol. 57, 1160– 1164 10.1136/jcp.2004.016238 15509676 PMC1770486 · DOI
  116. Yamagishi H. Srivastava D. (2003). Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome. Trends Mol. Med. 9, 383– 389 10.1016/S1471-4914(03)00141-2 13129704 · DOI
  117. Yamashita T. Honda M. Nio K. Nakamoto Y. Yamashita T. Takamura H. (2010). Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation. Cancer Res. 70, 4687– 4697 10.1158/0008-5472.CAN-09-4210 20484035 · DOI
  118. Yang X. Du W. W. Li H. Liu F. Khorshidi A. Rutnam Z. J. (2013). Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res. 41, 9688– 9704 10.1093/nar/gkt680 23990326 PMC3834805 · DOI
  119. Yin A. H. Miraglia S. Zanjani E. D. Almeida-Porada G. Ogawa M. Leary A. G. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90, 5002– 5012 9389720
  120. Yu F. Yao H. Zhu P. Zhang X. Pan Q. Gong C. (2007a). let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109– 1123 10.1016/j.cell.2007.10.054 18083101 · DOI
  121. Yu L. Baxter P. A. Voicu H. Gurusiddappa S. Zhao Y. Adesina A. (2010). A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol. 12, 580– 594 10.1093/neuonc/nop056 20511191 PMC2940646 · DOI
  122. Yu M. Bardia A. Wittner B. S. Stott S. L. Smas M. E. Ting D. T. (2013). Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580– 584 10.1126/science.1228522 23372014 PMC3760262 · DOI · Paper page

Cited by

Sorted by citations

See all 118

Metadata

Authors
Takahashi, R.-U., Miyazaki, H., & Ochiya, T.
Venue
Frontiers in Genetics
Publisher
Frontiers Media SA
Published
2014
Volume
4
ISSN
1664-8021
DOI
10.3389/fgene.2013.00295
PMC
PMC3879439
Cited by
118
References
9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review